June 5, 2019

Winship names Elkin Fellows and Rochfort Scholars

Photo of Winship names Elkin Fellows and Rochfort Scholars

Top left to right: Andres Chang, MD, PhD, Bassel Nazha, MD, MPH, and Neil Pfister, MD, PhD. Bottom left to right: Ashley Woods, MD, MS, Ibrahim Sahin, MD and Timothy Schmidt, MD

Six Winship trainees from Emory University School of Medicine are recipients of this year's Nell W. and William Simpson Elkin Fellowship and Chester Rochfort Scholarship. The awards are given out annually to extraordinary physician-scientists enrolled in eligible Emory training programs who have career goals in the research and treatment/prevention of cancer. Each award comes with an endowment of up to $35,000 to help cover salary, laboratory costs, and other research-related expenses, such as travel to conferences and meetings.

This cycle's Nell W. and William Simpson Elkin Fellowship recipients are:

  • Andres Chang, MD, PhD
    Fellow, Department of Hematology and Medical Oncology
    Project Title: PD-1 Expression in Chronic Lymphocytic Leukemia
  • Bassel Nazha, MD, MPH
    Fellow, Department of Hematology & Medical Oncology
    Project Title: Vasoactive intestinal peptide (VIP) and efficacy of immunotherapy of small cell lung cancer
  • Neil Pfister, MD, PhD
    Resident, Department of Radiation Oncology
    Project Title: Personalized Thoracic Radiotherapy for Non-Small Cell Lung Cancer Derived from CRISPR/Cas9 Genomic Screens
  • Ashley Woods, MD, MS
    Fellow, Department of Hematology and Medical Oncology
    Project Title: Enhancing Vaccine Response to Acute Myeloid Vaccines by Inhibiting the VIP Immune Checkpoint Pathway

This cycle's Chester Rochfort Scholarship recipients are:

  • Ibrahim Sahin, MD
    Fellow, Department of Hematology and Medical Oncology
    Project Title: Immune shift in rectal cancer after chemoradiotherapy
  • Timothy Schmidt, MD
    Fellow, Department of Hematology and Medical Oncology
    Project Title: MCL-1 Inhibition in Multiple Myeloma: A Study of Rapid BH3 Profiling and the Potential for Targeted Therapy
Cascade Link  TOP